Kodiak Sciences Inc (KOD)
Nasdaq: KOD · Biological Products, (No Diagnostic Substances) · Palo Alto, CA · filing with the SEC since 2009
Who runs Kodiak Sciences Inc
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Perlroth Victor
Chairman and CEO. First filing Oct 2018, latest Sep 29, 2026, 1 filing in all.
Officers reporting now
2
of 13 people with a filing in the last fifteen months
Directors reporting now
11
15 people on the record since 2018
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Borgeson John A. | Chief Financial Officer | Oct 2018 | Oct 23, 2026 | 14 · $4.9M |
| Perlroth Victor | Chairman and CEO | Oct 2018 | Sep 29, 2026 | none |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| 667, L.P. | director | Oct 2018 | Nov 6, 2026 | none |
| Baker Bros. Advisors (Gp) LLC | director | Oct 2018 | Nov 6, 2026 | none |
| Baker Bros. Advisors LP | director | Oct 2018 | Nov 6, 2026 | none |
| Baker Brothers Life Sciences LP | director | Oct 2018 | Nov 6, 2026 | none |
| Baker Felix | director | Oct 2018 | Nov 6, 2026 | none |
| Baker Julian | director | Oct 2018 | Nov 6, 2026 | none |
| Yang Taiyin | director | Dec 2019 | Oct 26, 2026 | none |
| Bancroft Charles A | director | Apr 2020 | Jul 2, 2026 | none |
| Dahiyat Bassil I | director | Oct 2018 | Jul 2, 2026 | none |
| Levy Richard S | director | Oct 2018 | Jul 2, 2026 | none |
| Profusek Robert | director | Oct 2018 | Jul 2, 2026 | none |
Earlier names on the record2, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.